The National Institutes of Health (NIH) intends to award a non-competitive purchase order to Purdue University for the synthesis, scale-up, and characterization of lead Spleen Tyrosine Kinase (SYK) inhibitors. This work is a continuation of ongoing research for a sickle cell disease study. Purdue University is the sole source due to their prior involvement and project-specific knowledge.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Synthesis, scale-up, and characterization of lead SYK inhibitor S1115
1
project
$125,000.00
$125,000.00
Professional Services
Synthesis, scale-up, and characterization of lead SYK inhibitor S1213
1
project
$125,000.00
$125,000.00
Professional Services
Estimated Bid Value
$250,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus the 1 document, contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.